Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Specialty pharmaceutical company Vestiq Pharmaceuticals is set to offer MagBID ER magnesium dietary supplement for patients who have lost magnesium because of illness or treatment with certain medicines.
Subscribe to our email newsletter
Praelia Pharmaceuticals, Vestiq’s supportive care company, will carry out the marketing and distribution activities of the product.
Formulated with 84mg of elemental magnesium L-lactate dehydrate in each MagBID ER caplet, four 84mg Mag-Tab SR caplets contain 336mg of magnesium meeting the USRDA range for the average adult female and male.
Praelia Pharmaceuticals president Steve Lutz said, "Because magnesium products’ solubility, absorption, and bioavailability affect patient response, it would likely require patients to take significantly more tablets of other magnesium products to provide the same amount of bioavailable magnesium as with each tablet of MagBID ER."
Low serum magnesium levels are believed to be associated with serious adverse events such as muscle spasm (tetany), irregular heartbeat (arrhythmias), and convulsions (seizures), according to the FDA.